Dmitry Balyasny Balyasny Asset Management
Dmitry Balyasny is the founder of Balyasny Asset Management, a major multi-strategy and multi-manager hedge fund platform. The firm allocates capital across fundamental equities, macro, quant, and other teams under a central risk framework. Balyasny’s platform is often cited alongside other leading pod-shop multi-strategy firms.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Visa
V
|
+$223M |
| 2 |
TJX Companies
TJX
|
+$191M |
| 3 |
TransDigm Group
TDG
|
+$157M |
| 4 |
Ingersoll Rand
IR
|
+$155M |
| 5 |
BP
BP
|
+$152M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ZEN
ZENDESK INC
ZEN
|
+$300M |
| 2 |
Eaton
ETN
|
+$261M |
| 3 |
Union Pacific
UNP
|
+$252M |
| 4 |
Analog Devices
ADI
|
+$240M |
| 5 |
SWCH
Switch, Inc. Class A Common Stock
SWCH
|
+$226M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Industrials | 11.39% |
| 2 | Financials | 11.28% |
| 3 | Technology | 9.98% |
| 4 | Consumer Discretionary | 9.35% |
| 5 | Healthcare | 8.59% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3151
Sabra Healthcare REIT
SBRA
$5.21B
| – | – |
-2,136,468
| Closed | -$28M |
|
3152
Sabesp
SBS
$16.2B
| – | – |
-191,374
| Closed | -$338K |
|
3153
Sibanye-Stillwater
SBSW
$8.9B
| – | – |
-100,000
| Closed | -$932K |
|
3154
PUT
Starbucks
SBUX
$122B
| – | – |
-18,900
| Closed | -$1.59M |
|
3155
Schrodinger
SDGR
$1.47B
| – | – |
-39,797
| Closed | -$995K |
|
3156
Sea Limited
SE
$72B
| – | – |
-36,786
| Closed | -$2.06M |
|
|
3157
PUT
Sea Limited
SE
$72B
| – | – |
-20,000
| Closed | -$1.12M |
|
3158
CALL
SolarEdge
SEDG
$1.9B
| – | – |
-5,000
| Closed | -$1.16M |
|
|
SEM
3159
DELISTED
Select Medical
SEM
| – | – |
-192,025
| Closed | -$2.29M |
|
3160
Steven Madden
SHOO
$3.37B
| – | – |
-19,566
| Closed | -$522K |
|
3161
PUT
Shopify
SHOP
$192B
| – | – |
-180,000
| Closed | -$4.85M |
|
3162
SITE Centers
SITC
$161M
| – | – |
-984,530
| Closed | -$8.23M |
|
3163
PUT
J.M. Smucker
SJM
$13.3B
| – | – |
-35,000
| Closed | -$4.81M |
|
3164
SkinHealth Systems
SKIN
$85M
| – | – |
-231,300
| Closed | -$2.5M |
|
3165
Solid Biosciences
SLDB
$997M
| – | – |
-1,982
| Closed | -$14K |
|
3166
SLM Corp
SLM
$4.97B
| – | – |
-53,116
| Closed | -$743K |
|
3167
SelectQuote
SLQT
$146M
| – | – |
-874,180
| Closed | -$638K |
|
3168
SLR Investment Corp
SLRC
$689M
| – | – |
-13,100
| Closed | -$161K |
|
3169
Snap-on
SNA
$20.3B
| – | – |
-25,467
| Closed | -$5.13M |
|
3170
Synopsys
SNPS
$76.2B
| – | – |
-71,605
| Closed | -$21.9M |
|
3171
TD Synnex
SNX
$20B
| – | – |
-15,156
| Closed | -$1.23M |
|
3172
CALL
SoFi Technologies
SOFI
$24.4B
| – | – |
-375,000
| Closed | -$1.83M |
|
|
3173
SoFi Technologies
SOFI
$24.4B
| – | – |
-298,726
| Closed | -$1.46M |
|
3174
Sonoco
SON
$5.88B
| – | – |
-70,170
| Closed | -$3.98M |
|
3175
Sonos
SONO
$1.87B
| – | – |
-320,337
| Closed | -$4.45M |
|
Similar funds
Dmitry Balyasny's Q4 2022 Portfolio in Review
As of Q4 2022, Dmitry Balyasny held 3,587 positions worth $36.5B, up 12% from $32.6B the previous quarter. Its ten largest holdings account for 7.7% of the portfolio.
Dmitry Balyasny's Q4 2022 filing shows 780 new, 747 increased, 671 reduced and 866 closed positions. Its largest new stake was TJX Companies: 2,589,145 shares worth $206M. The largest sale was ZENDESK INC, an estimated $300M.
By sector, the portfolio is most concentrated in Industrials at 11% of assets, down from 12% a quarter earlier, followed by Financials and Technology.
- Dmitry Balyasny's largest Q4 2022 buy was TJX Companies: 2,589,145 shares worth $206M.
- Dmitry Balyasny added most to Visa in Q4 2022, an estimated $223M increase.
- Dmitry Balyasny's biggest Q4 2022 reduction was Union Pacific, cutting an estimated $252M.
- Dmitry Balyasny fully exited ZENDESK INC in Q4 2022, selling an estimated $300M.
- Dmitry Balyasny's ten largest holdings make up 7.7% of its $36.5B portfolio in Q4 2022.
- Dmitry Balyasny opened 780 new positions and closed 866 in Q4 2022.
- Dmitry Balyasny's portfolio value rose 12% quarter-over-quarter to $36.5B.
Based on Balyasny Asset Management's 13F filing for Q4 2022, filed 14 Feb 2023.